Growth Metrics

ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2025)

ENDRA Life Sciences has reported Other Working Capital Changes over the past 6 years, most recently at $1.0 million for Q4 2021.

  • Quarterly Other Working Capital Changes rose 221.0% to $1.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $957203.0 through Dec 2021, up 867.51% year-over-year, with the annual reading at -$89252.0 for FY2025, 65.12% up from the prior year.
  • Other Working Capital Changes was $1.0 million for Q4 2021 at ENDRA Life Sciences, up from $507834.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $1.0 million in Q4 2021 and troughed at -$1.2 million in Q2 2020.
  • The 5-year median for Other Working Capital Changes is $7090.5 (2017), against an average of $63284.6.
  • Year-over-year, Other Working Capital Changes soared 32734.11% in 2018 and then crashed 1002.28% in 2020.
  • A 5-year view of Other Working Capital Changes shows it stood at $65610.0 in 2017, then tumbled by 102.26% to -$1484.0 in 2018, then skyrocketed by 3159.84% to $45408.0 in 2019, then surged by 604.92% to $320090.0 in 2020, then soared by 221.0% to $1.0 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Other Working Capital Changes are $1.0 million (Q4 2021), $507834.0 (Q3 2021), and -$561255.0 (Q2 2021).